New aspects of vaccination;Les nouveaux visages de la vaccination

Biofutur

Volumn , Issue 189, 1999, Pages 14-18

  Perrier, Jean Jacques ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DRUG VEHICLE; VACCINE;

DIARRHEA; DRUG EFFICACY; HEPATITIS C; HUMAN; IMMUNOTHERAPY; INFECTION; MENINGITIS; MYCOBACTERIUM TUBERCULOSIS; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; VACCINATION;

HEPATITIS C VIRUS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0032710698     PISSN: 02943506     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0294-3506(99)80395-0     Document Type: Short Survey

References (27)

1. G. Nossal, discours pour le lancement du Gates Children's Vaccine Program, 2 décembre 1998, Washington D.C. www.path.org/ childvac/
2. The Jordan Report 98, Division of Microbiology and Infectious Diseases, NIAID, National Institutes of Health, Bethesda, p. 1.
3. S.T. Cole et al. (1998) Nature 393, 537-544.
4. C. Leclerc, J. Ronco (1998) Immunol. Today 19, 300-302.
5. R.J. Gupta, G.R. Siber (1995) Vaccine 13, 1263-1276.
6. P. Palese et al. (1997) J. Infect. Dis. 176 Suppl. 1, S45-S49.
7. S. Baize et al. (1999) Nature Med. 5, 423-426.
8. Theta Reports (1998) Vaccine trends & developments worldwide. Juin 1998, New York.
9. B.R. Minev et al. (1999) Pharmacol. Ther. 81, 121-139.
10. K. Roy et al. (1999) Nature Med. 5, 387-391.
11. M. Paterson et al. (1998) Am. J. Reprod. Immunol. 40, 198-209.
12. S.B. Fox (1997) Drug Alcohol Depend. 48, 153-158.
13. T. Reiss, E. Strauss (1998) Exp. Opin. Ther. Patents 8, 951-958.
14. N.R. Rabinovich, G. Evans (1998) In : The Jordan Report 98, pp. 80-82.
15. Hépatites virales : dépistage, prévention, traitement. Inserm, Paris, 1997.
16. A. Kouchner (1998) L'Express, 8 octobre.
17. J.L. Cleland (1999) Trends Biotechnol. 17, 25-29.
18. Nature Medicine Vaccine Supplement (1998) 4, 485-517.
19. The Jordan Report 98. Accessible sur : www.niaid.nih.gov/
20. P. Evers (1998) Scrip's complete guide to vaccines. PJB Publications Ltd, Richmond, UK, 155 p.
21. S. Raychaudhuri, K.L. Rock (1998) Nature Biotechnol. 16, 1025-1031.
22. W.P. Hausdorff (1998) Drug Information J. 32, 13-17.
23. P. Romero et al. (1998) Mol. Med. Today 4, 305-312.
24. C. Leclerc (1995) La Recherche 276, 548-555.
25. OMS www.who.int/gpv/
26. Centers for disease control (CDC) www.cdc.gov/
27. Vaccine developpers www.ecbt.org/ pharm.htm